How Seeking Transfer Often Fails to Help Define Medically Inappropriate Treatment.
Hastings Cent Rep
; 54(2): 2, 2024 Mar.
Article
em En
| MEDLINE
| ID: mdl-38639166
ABSTRACT
On September 1, 2023, Texas made important revisions to it its decades-old statute granting legal safe harbor immunity to physicians who withhold or withdraw life-sustaining treatment over the objection of critically ill patients' surrogate decision-makers. However, lawmakers left untouched glaring flaws in a key safeguard for patients-the transfer option. The transfer option is ethically important because, when no hospital is willing to accept the patient in transfer, that fact is taken as strong evidence that the surrogates' treatment requests fall outside accepted medical practice. But there are serious shortcomings in how the transfer option is carried out in Texas and many other states, which undermines the ethical usefulness of the process. We identify these shortcomings and recommend revisions to state statutes and professional guidelines to overcome them.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Médicos
/
Tomada de Decisões
Limite:
Humans
Idioma:
En
Revista:
Hastings Cent Rep
Ano de publicação:
2024
Tipo de documento:
Article